See more : Aerosun Corporation (600501.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Noevir Holdings Co., Ltd. (4928.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Noevir Holdings Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- V-cube, Inc. (3681.T) Income Statement Analysis – Financial Results
- PT Sampoerna Agro Tbk (SGRO.JK) Income Statement Analysis – Financial Results
- Telstra Group Limited (TTRAF) Income Statement Analysis – Financial Results
- Cosel Co., Ltd. (6905.T) Income Statement Analysis – Financial Results
- Plotech Co.,Ltd (6141.TW) Income Statement Analysis – Financial Results
Noevir Holdings Co., Ltd. (4928.T)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.noevirholdings.co.jp
About Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparels and aircrafts. The company also produces and sells toiletries; purchases and sells makeup products and vessels; and provides market research services. In addition, it provides air transportation, charter flights, ground handling, and hanger rental services; and aircraft flight training, as well as undertakes aviation-related operations. The company sells its products through drug stores, specialty goods and general merchandise stores, supermarkets, online stores, and convenience stores, as well as approximately 2,000 Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63.82B | 62.55B | 61.14B | 51.27B | 51.84B | 59.25B | 57.83B | 54.47B | 51.18B | 49.39B | 48.25B | 46.52B | 47.22B | 0.00 | 52.58B | 55.23B | 58.67B |
| Cost of Revenue | 20.67B | 19.99B | 19.05B | 18.24B | 18.76B | 21.04B | 20.59B | 18.71B | 18.00B | 16.80B | 16.52B | 15.71B | 16.37B | 0.00 | 19.21B | 19.08B | 20.70B |
| Gross Profit | 43.16B | 42.56B | 42.09B | 33.03B | 33.08B | 38.21B | 37.24B | 35.76B | 33.19B | 32.59B | 31.73B | 30.81B | 30.85B | 0.00 | 33.37B | 36.14B | 37.97B |
| Gross Profit Ratio | 67.62% | 68.05% | 68.84% | 64.42% | 63.81% | 64.49% | 64.40% | 65.65% | 64.84% | 65.98% | 65.76% | 66.23% | 65.33% | 0.00% | 63.46% | 65.44% | 64.72% |
| Research & Development | 0.00 | 1.03B | 1.06B | 1.04B | 1.07B | 1.10B | 1.05B | 1.13B | 1.18B | 1.10B | 1.04B | 968.91M | 1.09B | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 20.85B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 122.85M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 10.92B | 10.69B | 11.06B | 4.88B | 5.20B | 5.94B | 6.19B | 6.43B | 6.44B | 6.13B | 5.81B | 5.19B | 5.46B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.92B | 31.54B | 11.06B | 4.88B | 5.20B | 5.94B | 6.19B | 6.43B | 6.44B | 6.13B | 5.81B | 5.19B | 5.58B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 20.82B | -1.03B | 20.92B | 18.55B | 18.75B | 19.18B | 18.65B | 101.00M | 170.00M | 216.00M | 230.12M | 180.43M | 274.73M | 0.00 | 30.59B | 98.00M | 33.93B |
| Operating Expenses | 31.73B | 31.54B | 31.98B | 24.47B | 25.02B | 26.22B | 25.89B | 25.77B | 25.47B | 24.99B | 24.67B | 23.56B | 16.51B | 0.00 | 30.59B | 32.60B | 33.93B |
| Cost & Expenses | 52.40B | 51.53B | 51.03B | 42.71B | 43.78B | 47.26B | 46.48B | 44.48B | 43.47B | 41.79B | 41.19B | 39.26B | 32.88B | 0.00 | 49.80B | 51.69B | 54.63B |
| Interest Income | 50.00M | 30.00M | 10.00M | 8.00M | 7.00M | 7.00M | 6.00M | 6.00M | 12.00M | 18.00M | 11.66M | 9.14M | 11.94M | 11.27M | 33.00M | 86.00M | 175.00M |
| Interest Expense | 0.00 | 0.00 | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 72.00M |
| Depreciation & Amortization | 1.01B | 1.22B | 1.45B | 1.49B | 1.70B | 1.82B | 1.90B | 1.89B | 1.70B | 1.28B | 1.06B | 1.11B | 1.70B | 912.76M | 1.90B | 2.13B | 2.67B |
| EBITDA | 12.44B | 12.24B | 11.57B | 10.05B | 9.76B | 13.81B | 13.24B | 11.88B | 9.41B | 8.87B | 8.52B | 8.62B | 7.23B | 7.35B | 4.71B | 5.62B | 8.08B |
| EBITDA Ratio | 19.48% | 19.57% | 17.69% | 19.35% | 18.85% | 25.26% | 22.85% | 21.64% | 18.41% | 18.98% | 16.96% | 18.07% | 53.26% | 0.00% | 8.97% | 10.59% | 11.73% |
| Operating Income | 11.42B | 11.02B | 10.12B | 8.56B | 8.06B | 11.99B | 11.34B | 9.99B | 7.71B | 7.59B | 7.06B | 7.25B | 14.34B | 0.00 | 2.78B | 3.54B | 4.04B |
| Operating Income Ratio | 17.90% | 17.62% | 16.54% | 16.69% | 15.55% | 20.24% | 19.62% | 18.33% | 15.06% | 15.36% | 14.64% | 15.59% | 30.36% | 0.00% | 5.29% | 6.41% | 6.89% |
| Total Other Income/Expenses | 196.00M | 274.00M | 1.05B | 409.00M | 173.00M | -959.00M | 261.00M | 303.00M | 109.00M | 489.00M | 394.93M | 255.71M | -8.81B | -4.87B | 31.00M | -48.00M | 1.30B |
| Income Before Tax | 11.62B | 11.30B | 11.16B | 8.97B | 8.23B | 11.03B | 11.60B | 10.29B | 7.82B | 8.08B | 7.46B | 7.51B | 5.53B | 0.00 | 2.81B | 3.49B | 5.34B |
| Income Before Tax Ratio | 18.21% | 18.06% | 18.25% | 17.49% | 15.88% | 18.62% | 20.07% | 18.89% | 15.27% | 16.35% | 15.46% | 16.14% | 11.70% | 0.00% | 5.35% | 6.32% | 9.10% |
| Income Tax Expense | 3.53B | 3.48B | 3.51B | 2.51B | 2.55B | 3.71B | 3.69B | 3.15B | 2.73B | 3.15B | 3.10B | 2.92B | 2.73B | 0.00 | 1.25B | 1.35B | 2.41B |
| Net Income | 7.97B | 7.67B | 7.59B | 6.38B | 5.62B | 7.23B | 7.84B | 7.08B | 5.05B | 4.89B | 4.35B | 4.58B | 2.79B | 0.00 | 1.57B | 2.15B | 2.94B |
| Net Income Ratio | 12.49% | 12.27% | 12.41% | 12.45% | 10.84% | 12.20% | 13.56% | 12.99% | 9.87% | 9.90% | 9.01% | 9.85% | 5.90% | 0.00% | 2.98% | 3.90% | 5.01% |
| EPS | 233.34 | 224.64 | 222.18 | 186.88 | 164.48 | 211.56 | 228.55 | 199.64 | 142.44 | 136.79 | 116.16 | 122.34 | 73.37 | 0.00 | 37.87 | 52.08 | 71.07 |
| EPS Diluted | 233.34 | 224.64 | 222.18 | 186.88 | 164.48 | 211.56 | 228.55 | 199.64 | 142.44 | 136.79 | 116.16 | 122.34 | 73.37 | 0.00 | 37.87 | 52.08 | 71.07 |
| Weighted Avg Shares Out | 34.16M | 34.16M | 34.16M | 34.16M | 34.16M | 34.16M | 34.31M | 35.45M | 35.45M | 35.75M | 37.44M | 37.44M | 37.99M | 41.32M | 41.32M | 41.32M | 41.32M |
| Weighted Avg Shares Out (Dil) | 34.16M | 34.16M | 34.16M | 34.16M | 34.16M | 34.16M | 34.31M | 35.45M | 35.45M | 35.75M | 37.44M | 37.44M | 37.99M | 41.32M | 41.32M | 41.32M | 41.32M |
Source: https://incomestatements.info
Category: Stock Reports